When it comes to the most serious conditions seen in the body, brain cancer will clearly be seen amongst them. There is so much detail to look into and the various substances and components often make finding remedies a challenging endeavor. However, with consistent efforts being seen in the medical field, recently a potential mechanism has been uncovered. With all of that said, is it possible that the mechanism in question could come into play for the sake of aiding research in ways that can prove much greater?
Companies along the lines of Voices against Brain Cancer know all too well just how complicated this particular condition can be. Brain cancer is complex and the various cells and substances that are seen lend credence to the idea that certain drugs can come into effect, provided they are safe. In many cases, as an article on Medical Xpress detailed, therapies primarily focus on the progression of glioma, the most malignant type of cancer. The article also detailed how an FDA-approved food additive could come into play.
The written piece on Medical Xpress talked about the food additive and how it was looked into by Diane M. Jaworski, a professor within the University of Vermont, as well as by former graduate Patrick Long. They focused on an enzyme by the name of aspartoacylase, which is needed in order to break down a chemical referred to as N-acetyl-L-aspartate. What NAA is responsible for is being the brain's primary storage form of acetate; what this means is that it is able to switch the genes in the brain on and off. For a glioma patient, both the levels of NAA and the expression of ASPA are not very high.
It seems as though there were various efforts done in order to help increase the levels of ASPA expressions but the article said that, unfortunately, proliferation resulted from it. However, the report made mention of a food additive to be utilized later on and it was called glyceryl triacetate. Not only would this potentially be able to help glioma patients but it has been implemented in order to assist patients with Canavan disease as well. This is an inherited condition that results in brain cell damage.
According to the article, GTA was put to use and the results that came to surface were rather positive. It showed lower levels of growth in terms of glioma stem cells but another positive to consider was that the healthy cells remained unharmed. This, to me, is the most important factor to consider about this condition. It shows that there is a level of potential to consider, especially when considering that toxicity and side-effects alike are practically nonexistent with GTA being put to use for research purposes.
Companies along the lines of Voices against Brain Cancer know all too well just how complicated this particular condition can be. Brain cancer is complex and the various cells and substances that are seen lend credence to the idea that certain drugs can come into effect, provided they are safe. In many cases, as an article on Medical Xpress detailed, therapies primarily focus on the progression of glioma, the most malignant type of cancer. The article also detailed how an FDA-approved food additive could come into play.
The written piece on Medical Xpress talked about the food additive and how it was looked into by Diane M. Jaworski, a professor within the University of Vermont, as well as by former graduate Patrick Long. They focused on an enzyme by the name of aspartoacylase, which is needed in order to break down a chemical referred to as N-acetyl-L-aspartate. What NAA is responsible for is being the brain's primary storage form of acetate; what this means is that it is able to switch the genes in the brain on and off. For a glioma patient, both the levels of NAA and the expression of ASPA are not very high.
It seems as though there were various efforts done in order to help increase the levels of ASPA expressions but the article said that, unfortunately, proliferation resulted from it. However, the report made mention of a food additive to be utilized later on and it was called glyceryl triacetate. Not only would this potentially be able to help glioma patients but it has been implemented in order to assist patients with Canavan disease as well. This is an inherited condition that results in brain cell damage.
According to the article, GTA was put to use and the results that came to surface were rather positive. It showed lower levels of growth in terms of glioma stem cells but another positive to consider was that the healthy cells remained unharmed. This, to me, is the most important factor to consider about this condition. It shows that there is a level of potential to consider, especially when considering that toxicity and side-effects alike are practically nonexistent with GTA being put to use for research purposes.
About the Author:
For extra details regarding brain maycer and how you may help, go to Voices against Brain maycer.. Also published at How Can A Mechanism Play Into Brain Cancer?.
0 comments:
Post a Comment